Yazar "Kaya, H." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    A New Needle Suspension Procedure for Genuine Stress Incontinence and Anterior Vaginal Wall Prolapse
    (Springer London, 1996) Çolakoğlu, M.; Çapar, M.; Kiliç, M.; Çolakoğlu, Ü.; Kaya, H.; Acar, A.
    A new suspension method was developed for the correction of anterior vaginal wall relaxation and genuine stress incontinence. This procedure suspends the anterior vaginal wall to the anterior rectus fascia, and in doing so gives support to the bladder neck, anterior vaginal wall and vaginal apex. The procedure is performed at the time of vaginal hysterectomy or correction of anterior vaginal wall relaxation. The authors present their experience with this technique in 31 patients.
  • Küçük Resim Yok
    Öğe
    The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone
    (MEDICAL SCIENCE PUBL INT, INC, 2004) Özkaya, O.; Kaya, H.; Sezik, M.; Akyürek, Cemalettin; Özbaşar, D.
    Objective-To compare basal (cycle day 3) follicle-stimulating hormone (FSH) level, clomiphene citrate challenge test (CCCT), gonadotropin-releasing hormone agonist stimulation test (GAST), and mean ovarian volume estimation by ultrasound for predicting the subsequent ovarian response. Design-Prospective, randomized, clinical study. Setting-Referral university hospital. Patients-One hundred and forty-four women with unexplained infertility undergoing their first ovulation induction treatment with low-dose recombinant FSH. Interventions-Patients were randomized into four groups. Basal FSH levels were evaluated in group I (n = 36). Clomiphene citrate challenge test (CCCT) and gonadotropin-releasing hormone agonist stimulation test (GAST) were carried out in group II (n = 36) and group III (n = 36), respectively. Transvaginal ultrasound was performed for ovarian volume measurements in group IV (n = 36). In the subsequent cycle, all women received ovulation induction therapy with recombinant FSH. Main Outcome Measures-Number of mature (greater than or equal to 14 mm) follicles and the number of recombinant FSH ampules required for successful ovulation induction. Results-Ovarian volume estimation by transvaginal ultrasound, compared to the other three tests, had the most powerful positive correlation with the number of mature follicles (r = 0.84, P < .0001) and the most powerful negative correlation (r = -0.75, P < .0001) with the amount of recombinant FSH used per cycle. Conclusion-Mean ovarian volume estimation by transvaginal ultrasound might be more useful than basal FSH values, CCCT, and GAST for predicting ovarian response to low-dose recombinant FSH treatment.